Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.43 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17287125 | 1.00 | ATM (0.47) | ATMALDH1A1NPSR1HPGDTSHR | |
| SCHEMBL6826471 | 1.00 | ATM (0.47) | ATMALDH1A1NPSR1HPGDTSHR | |
| SCHEMBL11026074 | 0.89 | HCAR2 (0.38) | ATMALDH1A1NPSR1TSHRADH1B | |
| SCHEMBL23044882 | 0.89 | HCAR2 (0.38) | ATMALDH1A1NPSR1TSHRADH1B | |
| SCHEMBL13746856 | 0.81 | NPSR1 (0.48) | ATMALDH1A1NPSR1HPGDTSHR | |
| SCHEMBL18510055 | 0.80 | ALDH1A1 (0.52) | ATMALDH1A1NPSR1HPGDTSHR | |
| SCHEMBL5527208 | 0.80 | MGAM (0.41) | ALDH1A1NPSR1ADH1BADH1CADH1A | |
| SCHEMBL18510017 | 0.80 | ALDH1A1 (0.52) | ATMALDH1A1NPSR1HPGDTSHR | |
| SCHEMBL7060302 | 0.80 | MGAM (0.41) | ALDH1A1NPSR1ADH1BADH1CADH1A | |
| SCHEMBL11028935 | 0.79 | CA12 (0.38) | ALDH1A1ADH1BADH1CADH1AADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114644577-A | Environment-friendly preparation method of substituted isonitrile compound | 新发药业有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-6740774-B1 | REACTING CARBOXAMIDE WITH GLYOXAL MONOACETAL DERIVATIVE | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-25 | — | — | US | disclosed |
| US-20030100790-A1 | Process for preparing N-formylamino carboxylic esters | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-29 | — | — | US | disclosed |
| EP-1310481-A1 | Process for the preparation of N-formyl-aminocarboxylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-14 | — | — | EP | disclosed |
| EP-1078916-B1 | Process for the preparation of N-acylaminoacid esters and N-acylaminoacetals | BASF AG (DE) | 2002-12-11 | — | — | EP | disclosed |
| EP-1078916-A1 | Process for the preparation of N-acylaminoacid esters and N-acylaminoacetals | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100790-A1 | Process for preparing N-formylamino carboxylic esters | DNPEP, QPCT, FPR3 | ATM 4093/4885ALDH1A1 1771/4885NPSR1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.